 Life Science Investor Mandates
(Aug. 10
- Aug. 16)
|
|
|
|
|
Looks US-Wide for Medtech Deals
|
Founds US VC to Invest in Seed Stage Life Science Deals
|
|
Invests in Early Stage Digital Health Opportunities
|
|
Invests in Therapeutics, Diagnostics and Devices in North America and Europe
|
|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
|
On Monday August 21st, Partnering for RESI Boston will open and all the entrepreneurs and investors attending the event will be able to start filling out their dance cards for RESI's one-on-one meetings. While RESI Partnering has always been the heart of the event, RESI also offers dozens of educational panels and workshops and also an engaging venue for ad-hoc networking.
The new Premier Partnering Plus will feature deep profiles of investors and strategic players that can be used to ensure attending startups get in front of the most relevant, best-fit buy side players possible. Below is a partial list of investors who are already signed up to take part. These investors range from family offices to major pharma players, from local funds to international cross border investors. Entrepreneurs can meet an incredible diversity of global investors at RESI Boston and continue the dialogue 6 weeks later at RESI NYC November 15...
|
 |
The LSN team reviews a lot of pitch decks on behalf of our clients, and we also hear many investor responses to startup presentations. We therefore have a unique window into what catches an investor's eye, and what makes them lose interest. In this article, we'll take a look at some common mistakes we've seen recently.
Tell Your Story
It's all too easy to fill a deck with information on your science and the market but not have any unifying message that brings this information together. A deck is much more likely to get you a meeting if it tells a cohesive story. What motivated you to start this company? What goal is your company working towards? How did your fellow founders get involved? The answers to these simple questions can build your deck's story and convince an investor to take a meeting. Remember, investors allocate to people rather than to assets - they need to know what your vision is and why you believe in this company. If you do this right, the investor will begin to believe in your company too...
|
|
With medical technology entrepreneurs facing a challenging capital landscape, angel capital remains a vital source of early stage funding in the sector. According to studies by the Angel Resource Institute, of every angel dollar invested in the USA, nearly 20 cents goes into healthcare and life sciences. In recognition of the importance of angel financing to early stage companies, RESI features two angel panels, and today we would like to announce our Medtech Angels panel for RESI Boston. If you're interested in how to pitch to an angel group, what makes a medtech opportunity suitable for angel investment, or how angels work with their portfolio companies to hit subsequent milestones and follow-on raises, this panel is for you.
LSN has brought together five highly experienced angels who have a focus on medical technology investment. The participants are:
- Laura Davis - Managing Director, Golden Seeds
- Eric Dobson - CEO, Angel Capital Group
- Harald Stock - Managing Partner, Alta Life Science
- Bernie Rudnick - Founding Member, Mid Atlantic Bio Angels
- Bob Williams - Angel Investor, Life Sciences Angel Network
|
|
|
|
|
|
|
